<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1242" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1242/" /><meta name="ncbi_pagename" content="GARS1-Associated Axonal Neuropathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>GARS1-Associated Axonal Neuropathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="GARS1-Associated Axonal Neuropathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/11/29" /><meta name="citation_author" content="Anthony Antonellis" /><meta name="citation_author" content="Lev G Goldfarb" /><meta name="citation_author" content="Kumaraswamy Sivakumar" /><meta name="citation_pmid" content="20301420" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1242/" /><meta name="citation_keywords" content="Charcot-Marie-Tooth Neuropathy Type 2D (CMT2D)" /><meta name="citation_keywords" content="Distal Spinal Muscular Atrophy V (dSMA-V)" /><meta name="citation_keywords" content="Glycine--tRNA ligase" /><meta name="citation_keywords" content="GARS1" /><meta name="citation_keywords" content="GARS-Associated Axonal Neuropathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="GARS1-Associated Axonal Neuropathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Anthony Antonellis" /><meta name="DC.Contributor" content="Lev G Goldfarb" /><meta name="DC.Contributor" content="Kumaraswamy Sivakumar" /><meta name="DC.Date" content="2018/11/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1242/" /><meta name="description" content="GARS1-associated axonal neuropathy (Charcot-Marie-Tooth neuropathy type 2D / distal spinal muscular atrophy V [CMT2D/dSMA-V]) is characterized by adolescent or early-adult onset of weakness in the hands that may be preceded by transient cramping and pain in the hands on exposure to cold and cramping in calf muscles on exertion. This is followed by progressive weakness and atrophy of thenar and first dorsal interosseus muscles; hypothenar eminence is spared until later in the course of illness. The lower limbs are involved in about half of affected individuals, with severity varying from weakness and atrophy of the extensor digitorum brevis and weakness of toe dorsiflexors to classic peroneal muscular atrophy with foot drop. The phenotype is considered the CMT2D subtype when sensory deficits (reduction of pinprick, temperature, touch, and vibration perception in a stocking and [less often] glove pattern) are present and dSMA-V when sensory deficits are absent." /><meta name="og:title" content="GARS1-Associated Axonal Neuropathy" /><meta name="og:type" content="book" /><meta name="og:description" content="GARS1-associated axonal neuropathy (Charcot-Marie-Tooth neuropathy type 2D / distal spinal muscular atrophy V [CMT2D/dSMA-V]) is characterized by adolescent or early-adult onset of weakness in the hands that may be preceded by transient cramping and pain in the hands on exposure to cold and cramping in calf muscles on exertion. This is followed by progressive weakness and atrophy of thenar and first dorsal interosseus muscles; hypothenar eminence is spared until later in the course of illness. The lower limbs are involved in about half of affected individuals, with severity varying from weakness and atrophy of the extensor digitorum brevis and weakness of toe dorsiflexors to classic peroneal muscular atrophy with foot drop. The phenotype is considered the CMT2D subtype when sensory deficits (reduction of pinprick, temperature, touch, and vibration perception in a stocking and [less often] glove pattern) are present and dSMA-V when sensory deficits are absent." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1242/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cmt2d/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1242/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DE383DFC83FD100000000076F037C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1242_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1242_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/g6pc3-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gata1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1242_"><span class="title" itemprop="name"><i>GARS1</i>-Associated Axonal Neuropathy</span></h1><p class="contrib-group"><span itemprop="author">Anthony Antonellis</span>, PhD, <span itemprop="author">Lev G Goldfarb</span>, MD, and <span itemprop="author">Kumaraswamy Sivakumar</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1242_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1242_ai__"><div class="contrib half_rhythm"><span itemprop="author">Anthony Antonellis</span>, PhD<div class="affiliation small">Department of Human Genetics<br />University of Michigan Medical School<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu@llenotna" class="oemail">ude.hcimu@llenotna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lev G Goldfarb</span>, MD<div class="affiliation small">National Institute of Neurological Disorders and Stroke<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.sdnin@lbrafdlog" class="oemail">vog.hin.sdnin@lbrafdlog</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kumaraswamy Sivakumar</span>, MD<div class="affiliation small">Neuromuscular Research Center<br />Barrow Neurological Institute<br />St Joseph's Hospital and Medical Center<br />Phoenix, Arizona<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.ralucsumoruenza@ramukavisk" class="oemail">gro.ralucsumoruenza@ramukavisk</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 8, 2006</span>; Last Update: <span itemprop="dateModified">November 29, 2018</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cmt2d.Summary" itemprop="description"><h2 id="_cmt2d_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>GARS1</i>-associated axonal neuropathy (Charcot-Marie-Tooth neuropathy type 2D / distal spinal muscular atrophy V [CMT2D/dSMA-V]) is characterized by adolescent or early-adult onset of weakness in the hands that may be preceded by transient cramping and pain in the hands on exposure to cold and cramping in calf muscles on exertion. This is followed by progressive weakness and atrophy of thenar and first dorsal interosseus muscles; hypothenar eminence is spared until later in the course of illness. The lower limbs are involved in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, with severity varying from weakness and atrophy of the extensor digitorum brevis and weakness of toe dorsiflexors to classic peroneal muscular atrophy with foot drop. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is considered the CMT2D subtype when sensory deficits (reduction of pinprick, temperature, touch, and vibration perception in a stocking and [less often] glove pattern) are present and dSMA-V when sensory deficits are absent.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>GARS1</i>-associated axonal neuropathy is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GARS1</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Assistive devices for weak hands; ankle support, toe-up braces, ankle-foot orthotics as necessary to improve gait.</p><p><i>Surveillance</i>: Assessment every six months by a neurologist and/or neuromuscular disorders specialist to assess progression of weakness in the limbs and determine the need for prosthetic or assistive devices.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>GARS1</i>-associated axonal neuropathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with the disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown. Each child of an individual with <i>GARS1</i>-associated axonal neuropathy has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible if the pathogenic variant has been identified in an affected family member.</p></div></div><div id="cmt2d.GeneReview_Scope"><h2 id="_cmt2d_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="cmt2d.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2d.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GARS1</i>-Associated Axonal Neuropathy: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_cmt2d.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Charcot-Marie-Tooth neuropathy type 2D (CMT2D)</div></li><li class="half_rhythm"><div>Distal spinal muscular atrophy V (dSMA-V)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#cmt2d.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="cmt2d.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#cmt2d.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="cmt2d.Diagnosis"><h2 id="_cmt2d_Diagnosis_">Diagnosis</h2><p>Charcot-Marie-Tooth neuropathy type 2D (CMT2D) characterized by distal motor and sensory neuropathy [<a class="bk_pop" href="#cmt2d.REF.ionasescu.1996.1373">Ionasescu et al 1996</a>] and distal spinal muscular atrophy V (dSMA-V) with exclusively motor distal involvement [<a class="bk_pop" href="#cmt2d.REF.christodoulou.1995.1629">Christodoulou et al 1995</a>] were originally thought to be distinct entities, but family studies [<a class="bk_pop" href="#cmt2d.REF.sambuughin.1998.23">Sambuughin et al 1998</a>, <a class="bk_pop" href="#cmt2d.REF.ellsworth.1999.568">Ellsworth et al 1999</a>] and later molecular genetic studies [<a class="bk_pop" href="#cmt2d.REF.antonellis.2003.1293">Antonellis et al 2003</a>] determined that they represent the clinical spectrum associated with pathogenic variants in <i>GARS1</i>. In this <i>GeneReview</i> the term "<i>GARS1</i>-associated axonal neuropathy" comprises both allelic disorders.</p><div id="cmt2d.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>GARS1</i>-associated axonal neuropathy <b>should be suspected</b> in individuals with the following findings:</p><ul><li class="half_rhythm"><div class="half_rhythm">Adolescent or early-adult onset of bilateral weakness and atrophy of thenar and first dorsal interosseus muscles with progression to involve hypothenar, foot, and peroneal muscles in many individuals and mild to moderate impairment of vibration sense developing in advanced illness in some individuals (dSMA-V <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</div></li><li class="half_rhythm"><div class="half_rhythm">Presence of sensory deficits including reduction of pinprick, temperature, touch, and vibration perception in a stocking and (less often) glove pattern (CMT2D <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</div></li><li class="half_rhythm"><div class="half_rhythm">Chronic denervation on EMG in distal muscles with reduced compound motor action potentials at near-normal or normal motor conduction velocities and preserved sensory nerve action potentials (SNAPs), including the sural response. See <a href="#cmt2d.Electrophysiologic_Studies">Electrophysiologic Studies</a>.</div></li><li class="half_rhythm"><div class="half_rhythm">Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div><div class="half_rhythm">Note: Individuals with a negative family history and a more severe, early-onset <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have been described [<a class="bk_pop" href="#cmt2d.REF.eskuri.2012.132">Eskuri et al 2012</a>].</div></li></ul><div id="cmt2d.Electrophysiologic_Studies"><h4>Electrophysiologic Studies</h4><p>EMG shows denervation predominantly in the distal muscle groups at normal motor distal latencies and conduction velocities (see <a class="figpopup" href="/books/NBK1242/table/cmt2d.T.results_of_electrophysiologic_st/?report=objectonly" target="object" rid-figpopup="figcmt2dTresultsofelectrophysiologicst" rid-ob="figobcmt2dTresultsofelectrophysiologicst">Table 1</a>):</p><ul><li class="half_rhythm"><div>Absent or markedly reduced (frequently &#x0003c;1 mV) compound muscle action potentials (CMAPs) are recorded from the abductor pollicis brevis (APB) by median nerve stimulation [<a class="bk_pop" href="#cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</a>].</div></li><li class="half_rhythm"><div>Preserved CMAPs are recorded from the abductor digiti minimi (ADM) by ulnar nerve stimulation.</div></li><li class="half_rhythm"><div>CMAP amplitude recorded by stimulation of the peroneal nerve is &#x0003c;2 mV in most individuals and &#x0003c;1 mV in individuals having clinically evident leg atrophy.</div></li><li class="half_rhythm"><div>Normal median SNAP amplitudes and conduction velocities are seen in most individuals, even those with mildly prolonged distal motor latency.</div></li><li class="half_rhythm"><div>In individuals with advanced disease, needle EMG shows no voluntary motor activity in the abductor pollicis and first dorsal interossei because of marked atrophy. Spontaneous activity is often seen in these muscles.</div></li><li class="half_rhythm"><div>The elicited sural SNAPs are preserved but with a reduced amplitude, despite sensory axonal loss identified histopathologically on examination of a sensory nerve from an individual with the CMT2D subtype; similar but milder changes were seen in individuals with dSMA-V.</div></li></ul><p>Note: EMG is more widely available than nerve biopsy, which can be used in a single individual in a family or in diagnostically difficult cases. See <a href="#cmt2d.Nerve_Biopsy">Nerve Biopsy</a>.</p><div id="cmt2d.T.results_of_electrophysiologic_st" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Results of Electrophysiologic Studies in <i>GARS1</i>-Associated Axonal Neuropathy by Subtype</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.T.results_of_electrophysiologic_st/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.T.results_of_electrophysiologic_st_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="2" colspan="3" scope="colgroup" headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" style="text-align:left;vertical-align:middle;">Results of Electrophysiologic Studies</th><th id="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Subtype</th></tr><tr><th headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2" id="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">CMT2D (%)</th><th headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2" id="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">dSMA-V (%)</th></tr></thead><tbody><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="9" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Motor nerve conduction</b></td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><b>Compound</b><br /><b>muscle action</b><br /><b>potential</b></td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Median-APB &#x0003c;4.5 mV</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Ulnar-ADM &#x0003c;3.5 mV</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Peroneal-EDB &#x0003c;2 mV</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">62.5</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Tibial-AH &#x0003c;2.5 mV</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="3" colspan="1" scope="row" style="text-align:left;vertical-align:middle;"><b>Distal motor latency</b></td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Median &#x0003c;5.6 ms</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Ulnar &#x0003c;4.5 ms</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Peroneal &#x00026; tibial &#x0003c;7.5 ms</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="2" colspan="1" scope="row" style="text-align:left;vertical-align:middle;"><b>Nerve conduction velocity</b></td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Median &#x00026; ulnar &#x0003c;39 m/s</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Peroneal &#x00026; tibial &#x0003c;29 m/s</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="2" colspan="2" scope="row" style="text-align:left;vertical-align:middle;"><b>Sensory nerve conduction:</b><br /><b>sensory nerve action potential</b></td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Median &#x0003c;10 &#x000b5;V; ulnar &#x0003c;8 &#x000b5;V</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td></tr><tr><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sural &#x0003c;6 &#x000b5;V</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17</td><td headers="hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_h_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">29</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADM = abductor digiti minimi; AH = adductor halluces; APB = abductor pollicis brevis; EDB = extensor digitorum brevis</p></div></dd></dl></div></div></div></div></div><div id="cmt2d.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>GARS1</i>-associated axonal neuropathy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GARS1</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1242/table/cmt2d.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figcmt2dTmoleculargenetictestingusedi" rid-ob="figobcmt2dTmoleculargenetictestingusedi">Table 2</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, concurrent or serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>GARS1</i>-associated axonal neuropathy is potentially broad, individuals with the distinctive findings described in <a href="#cmt2d.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#cmt2d.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from other inherited disorders with neuromuscular weakness or sensory deficits in whom the diagnosis of <i>GARS1</i>-associated axonal neuropathy has not been considered are more likely to be diagnosed using genomic testing (see <a href="#cmt2d.Option_2">Option 2</a>).</p><div id="cmt2d.Option_1"><h4>Option 1</h4><p>When phenotypic and laboratory findings suggest the diagnosis of <i>GARS1</i>-associated axonal neuropathy, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>GARS1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GARS1</i> and other genes of interest (see <a href="#cmt2d.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="cmt2d.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from other inherited disorders characterized by neuromuscular weakness or sensory deficits or when the diagnosis of <i>GARS1</i>-associated axonal neuropathy is not considered because an individual has atypical phenotypic features, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cmt2d.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>GARS1</i>-Associated Axonal Neuropathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GARS1</i></td><td headers="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_cmt2d.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cmt2d.TF.2.1"><p class="no_margin">See <a href="/books/NBK1242/#cmt2d.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cmt2d.TF.2.2"><p class="no_margin">See <a href="#cmt2d.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cmt2d.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cmt2d.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#cmt2d.REF.antonellis.2003.1293">Antonellis et al [2003]</a>, <a class="bk_pop" href="#cmt2d.REF.james.2006.1710">James et al [2006]</a>, <a class="bk_pop" href="#cmt2d.REF.lee.2012.418">Lee et al [2012]</a>, <a class="bk_pop" href="#cmt2d.REF.divincenzo.2014.522">DiVincenzo et al [2014]</a>, <a class="bk_pop" href="#cmt2d.REF.antoniadi.2015.84">Antoniadi et al [2015]</a></p></div></dd><dt>5. </dt><dd><div id="cmt2d.TF.2.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cmt2d.TF.2.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="cmt2d.Clinical_Characteristics"><h2 id="_cmt2d_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cmt2d.Clinical_Description"><h3>Clinical Description</h3><p>In this <i>GeneReview</i> the term "<i>GARS1</i>-associated axonal neuropathy" includes both Charcot-Marie-Tooth neuropathy type 2D (CMT2D), characterized by distal motor and sensory neuropathy, and distal spinal muscular atrophy V (dSMA-V), with exclusively motor distal involvement.</p><p><b>Onset.</b> Both disease subtypes, CMT2D and dSMA-V, are characterized by adolescent or early-adult onset of unique patterns of motor and sensory manifestations. Age of onset ranges from eight to 36 years, with most individuals (75%) developing symptoms during the second decade of life [<a class="bk_pop" href="#cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</a>, <a class="bk_pop" href="#cmt2d.REF.james.2006.1710">James et al 2006</a>]. However, infantile onset has also been reported in individuals who have <i>de novo GARS1</i> pathogenic variants [<a class="bk_pop" href="#cmt2d.REF.eskuri.2012.132">Eskuri et al 2012</a>].</p><p><b>Presentation.</b> The presenting symptom is typically muscle weakness in the hands. The earliest elicited manifestations of illness in many individuals are transient cramping and pain in the hands on exposure to cold and cramping in calf muscles on exertion. Progressive weakness and atrophy of the thenar and first dorsal interosseus muscles are the major complaints in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (<a class="figpopup" href="/books/NBK1242/figure/cmt2d.F1/?report=objectonly" target="object" rid-figpopup="figcmt2dF1" rid-ob="figobcmt2dF1">Figure 1</a>, <a class="figpopup" href="/books/NBK1242/table/cmt2d.T.phenotypic_features_of_gars1asso/?report=objectonly" target="object" rid-figpopup="figcmt2dTphenotypicfeaturesofgars1asso" rid-ob="figobcmt2dTphenotypicfeaturesofgars1asso">Table 3</a>). The hypothenar eminence is spared until later in the course of illness.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcmt2dF1" co-legend-rid="figlgndcmt2dF1"><a href="/books/NBK1242/figure/cmt2d.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figcmt2dF1" rid-ob="figobcmt2dF1"><img class="small-thumb" src="/books/NBK1242/bin/cmt2d-Image001.gif" src-large="/books/NBK1242/bin/cmt2d-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndcmt2dF1"><h4 id="cmt2d.F1"><a href="/books/NBK1242/figure/cmt2d.F1/?report=objectonly" target="object" rid-ob="figobcmt2dF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Distribution of muscle weakness and atrophy in individuals with two major clinical subtypes of <i>GARS1</i>-associated disease A. Thenar and first dorsal interosseus muscle wasting with relatively preserved hypothenar in an individual with dSMA-V phenotype</p></div></div><p>The lower limbs are involved in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Lower extremity involvement, when present, varies in severity from weakness and atrophy of the extensor digitorum brevis and weakness of toe dorsiflexors to classic peroneal muscular atrophy with foot drop. Peroneal muscles are affected earlier and more severely than the calf muscles. If peroneal muscular atrophy develops, it is associated with <i>pes cavus</i> and moderate sensory abnormalities in stocking distribution and (less often) glove distribution. Individuals with lower-leg involvement have a high steppage gait.</p><p>Reflexes at the ankles are diminished or absent in individuals with leg muscle weakness and sensory deficits.</p><p>Sensory examination is either normal or shows mild to moderate impairment of vibration sense in the hands and feet; in individuals with the CMT2D subtype, reduction of pinprick, temperature, touch, and vibration perception in a stocking and (less often) glove pattern is observed (<a class="figpopup" href="/books/NBK1242/table/cmt2d.T.phenotypic_features_of_gars1asso/?report=objectonly" target="object" rid-figpopup="figcmt2dTphenotypicfeaturesofgars1asso" rid-ob="figobcmt2dTphenotypicfeaturesofgars1asso">Table 3</a>). In individuals with the dSMA-V subtype, sensory deficits are absent.</p><p>Proximal limb muscle weakness is not observed in the upper or lower extremities.</p><div id="cmt2d.T.phenotypic_features_of_gars1asso" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Phenotypic Features of <i>GARS1</i>-Associated Axonal Neuropathy by Subtype</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.T.phenotypic_features_of_gars1asso/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.T.phenotypic_features_of_gars1asso_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" style="text-align:left;vertical-align:middle;">Symptoms and Signs</th><th id="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Subtype</th></tr><tr><th headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2" id="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">CMT2D (%)</th><th headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2" id="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">dSMA-V (%)</th></tr></thead><tbody><tr><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive bilateral weakness and wasting of thenar and FDI muscles</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td></tr><tr><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peroneal weakness with atrophy and <i>pes cavus</i></td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">57.5</td></tr><tr><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal dysfunction</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12.5</td></tr><tr><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduced sensation for touch, pain, and temperature</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td></tr><tr><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduced vibration sense</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100</td><td headers="hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_1_2 hd_h_cmt2d.T.phenotypic_features_of_gars1asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">37.5</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#cmt2d.REF.sivakumar.2005.2304">Sivakumar et al [2005]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">FDI = first dorsal interosseus</p></div></dd></dl></div></div></div><div id="cmt2d.Nerve_Biopsy"><h4>Nerve Biopsy</h4><p>The dSMA-V subtype shows clear signs of axonal pathology with two or more regenerative clusters per fascicle (<a class="figpopup" href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" rid-figpopup="figcmt2dF2" rid-ob="figobcmt2dF2">Figure 2A</a>). No evidence of active degeneration and no obvious signs of demyelination or typical onion bulb formation are present. Myelin structures appear normal. Overall myelinated fiber density is normal (<a class="figpopup" href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" rid-figpopup="figcmt2dF2" rid-ob="figobcmt2dF2">Figure 2B</a>). Fibers &#x0003e;7 mm in diameter represent 52% of the overall number of fibers in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual compared to 65% in control specimens. Electron microscopy (EM) shows denervated Schwann cell subunits as indicated by an increased number of profiles, suggesting damage to small unmyelinated nerve fibers (UMNFs) (<a class="figpopup" href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" rid-figpopup="figcmt2dF2" rid-ob="figobcmt2dF2">Figure 2C</a>). The UMNF density is at the low normal level.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcmt2dF2" co-legend-rid="figlgndcmt2dF2"><a href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figcmt2dF2" rid-ob="figobcmt2dF2"><img class="small-thumb" src="/books/NBK1242/bin/cmt2d-Image002.gif" src-large="/books/NBK1242/bin/cmt2d-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndcmt2dF2"><h4 id="cmt2d.F2"><a href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" rid-ob="figobcmt2dF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Sural nerve morphology in <i>GARS1</i>-related dSMA-V and CMT2D phenotypes A. dSMA-V. Pathologic changes are minimal with a near-normal myelinated nerve fiber density.</p></div></div><p>The CMT2D subtype shows clear evidence of axonal pathology in nerve biopsy in one individual. Axonal swelling with filamentous accumulations (<a class="figpopup" href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" rid-figpopup="figcmt2dF2" rid-ob="figobcmt2dF2">Figure 2D</a>) and four to eight regenerative clusters per fascicle are observed (<a class="figpopup" href="/books/NBK1242/figure/cmt2d.F2/?report=objectonly" target="object" rid-figpopup="figcmt2dF2" rid-ob="figobcmt2dF2">Figure 2E</a>). Pseudo-onion bulb formations and a few thinly myelinated fibers are seen. Myelin structures appear intact. Overall myelinated fiber density is reduced. The proportion of fibers &#x0003c;7 mm in diameter is only 46%. Denervation of Schwann cell subunits as indicated by an increased number of profiles is seen on EM.</p></div></div><div id="cmt2d.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The <i>GARS1</i> variants p.Leu183Pro and p.His472Arg are exclusively associated with the dSMA-V clinical subtype; p.Gly294Arg, p.Ile334Phe, and p.Gly580Arg are associated with the CMT2D subtype. The variants p.Glu125Gly, p.Pro298Leu, and p.Asp554Asn are identified in families with both subtypes. Finally, the variant p.Gly652Ala has been associated with infantile-onset <i>GARS1</i>-associated axonal neuropathy [<a class="bk_pop" href="#cmt2d.REF.eskuri.2012.132">Eskuri et al 2012</a>] (see <a class="figpopup" href="/books/NBK1242/table/cmt2d.T.gars1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figcmt2dTgars1pathogenicvariantsdiscus" rid-ob="figobcmt2dTgars1pathogenicvariantsdiscus">Table 4</a>).</p></div><div id="cmt2d.Penetrance"><h3>Penetrance</h3><p>Penetrance is incomplete in this disorder, although specific data are not available.</p></div><div id="cmt2d.Nomenclature"><h3>Nomenclature</h3><p>The term "<i>GARS1</i>-associated axonal neuropathy" includes an axonal form of CMT type 2 and a similar group of clinical syndromes classified as distal hereditary motor neuropathy or distal spinal muscular atrophy (dSMA-V). <i>GARS1</i>-associated axonal neuropathy is considered the CMT2D subtype when sensory deficits (reduction of pinprick, temperature, touch, and vibration perception in a stocking and [less often] glove pattern) are present, and dSMA-V when sensation is normal or a sensory response is present on nerve conduction studies alone.</p><p>Using the classification system (based on the results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in the context of inheritance, neurologic examination, and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>) proposed by <a class="bk_pop" href="#cmt2d.REF.magy.2018.e870">Magy et al [2018]</a>, CMT2D would be referred to as AD-CMTAx-<i>GARS1</i>.</p></div><div id="cmt2d.Prevalence"><h3>Prevalence</h3><p>Disease prevalence is unknown; <i>GARS1</i>-associated axonal neuropathy is likely very rare. For example, fewer than 25 disease-associated <i>GARS1</i> alleles have been described and the vast majority are specific to individual pedigrees [<a class="bk_pop" href="#cmt2d.REF.meyerschuman.2017.r114">Meyer-Schuman &#x00026; Antonellis 2017</a>].</p></div></div><div id="cmt2d.Genetically_Related_Allelic_Disord"><h2 id="_cmt2d_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>In addition to dominant peripheral neuropathy, compound heterozygosity for <i>GARS1</i> pathogenic variants has been implicated in a severe, multisystem, recessive disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that includes severe prenatal-onset growth restriction and developmental delays [<a class="bk_pop" href="#cmt2d.REF.oprescu.2017.1412">Oprescu et al 2017</a>].</p></div><div id="cmt2d.Differential_Diagnosis"><h2 id="_cmt2d_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>GARS1</i>-associated axonal neuropathy needs to be distinguished from other forms of CMT, spinal muscular atrophy (SMA), and unrelated but similar neurologic conditions.</p><p><a href="/books/n/gene/cmt2/"><b>Charcot-Marie-Tooth disease type 2</b></a>
<b>(CMT2).</b> Other subtypes of CMT2 have a wide range of onset age and diverse manifestations. Generally, individuals with CMT2 present with distal muscular atrophy, loss of reflexes, sensory deficits, reduced sensory nerve action potentials (SNAPs), and normal or mildly slowed motor nerve conduction velocity. The unique pattern of hand involvement before leg involvement and preserved SNAPs helps distinguish CMT2D from other CMT2 subtypes.</p><p><b>Distal spinal muscular atrophy (dSMA).</b> Other types of dSMA (also referred to as distal hereditary motor neuropathy [dHMN]) &#x02013; a genetically heterogeneous group of disorders [<a class="bk_pop" href="#cmt2d.REF.irobi.2004a.r195">Irobi et al 2004a</a>, <a class="bk_pop" href="#cmt2d.REF.irobi.2004b.597">Irobi et al 2004b</a>] caused by progressive degeneration of anterior horn neurons &#x02013; are characterized by slowly progressive muscle weakness and atrophy in the distal limbs without sensory deficits. SNAPs are preserved and motor conduction velocities are nearly normal. A separate set of genes is associated with dHMN-V subtypes [<a class="bk_pop" href="#cmt2d.REF.irobi.2004a.r195">Irobi et al 2004a</a>, <a class="bk_pop" href="#cmt2d.REF.irobi.2004b.597">Irobi et al 2004b</a>]. The pattern of hand involvement before leg involvement distinguishes dHMN-V from other dHMN subtypes.</p><p><b>Silver syndrome</b> is associated with spasticity in the legs and amyotrophy in the hands. Caused by pathogenic variants in <i>BSCL2</i>, Silver syndrome is part of the spectrum of the <a href="/books/n/gene/spg17/"><i>BSCL2</i>-related neurologic disorders</a>. In contrast to Silver syndrome, in which most individuals have spasticity, only a minority of individuals with <i>GARS1</i>-associated axonal neuropathy show mild pyramidal signs and spasticity (<a class="figpopup" href="/books/NBK1242/table/cmt2d.T.phenotypic_features_of_gars1asso/?report=objectonly" target="object" rid-figpopup="figcmt2dTphenotypicfeaturesofgars1asso" rid-ob="figobcmt2dTphenotypicfeaturesofgars1asso">Table 3</a>) [<a class="bk_pop" href="#cmt2d.REF.christodoulou.1995.1629">Christodoulou et al 1995</a>, <a class="bk_pop" href="#cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</a>, <a class="bk_pop" href="#cmt2d.REF.dubourg.2006.1721">Dubourg et al 2006</a>].</p><p><b>Other neurologic disorders.</b> The clinical pattern of disease onset with hand weakness and atrophy rather than foot involvement and absent sensory deficits in the early stages of the illness should raise a suspicion of carpal tunnel syndrome, neurogenic thoracic outlet syndrome, or multifocal motor neuropathy:</p><ul><li class="half_rhythm"><div>In the absence of family history, paresthesia, and pain, the clinical pattern of median nerve dysfunction at the wrist in individuals with carpal tunnel syndrome may be similar to that seen in the early stages of <i>GARS1</i>-associated axonal neuropathy. Carpal tunnel syndrome is usually asymmetric and limited to median nerve.</div></li><li class="half_rhythm"><div>Compression of the lower cervical and T1 roots caused by a cervical rib may result in neurogenic thoracic outlet syndrome. In this condition, thenar, hypothenar, and interossei weakness/atrophy is associated with ulnar and medial antebrachial cutaneous hypesthesia that could be validated by nerve conduction studies showing reduced SNAP amplitudes in the medial antebrachial cutaneous and ulnar nerves.</div></li><li class="half_rhythm"><div>Multifocal motor neuropathy is a <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> autoimmune demyelinating disease causing slowly progressing motor disturbances in peripheral nerve distributions, predominantly in the distal upper extremities. It is often asymmetric and eventually involves hand muscles innervated by two or more motor nerves. Electrophysiologic conduction block can be demonstrated in the motor nerves, and anti-GM1 antibody titers are often elevated.</div></li></ul></div><div id="cmt2d.Management"><h2 id="_cmt2d_Management_">Management</h2><div id="cmt2d.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>GARS1</i>-associated axonal neuropathy, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Nerve conduction studies and EMG of arms and legs</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cmt2d.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Appropriate treatment includes the following:</p><ul><li class="half_rhythm"><div>Prosthetic and adaptive devices for weak hands. Numerous devices are available for various activities of daily living.</div></li><li class="half_rhythm"><div>Ankle support, toe-up braces, and ankle-foot orthotics as necessary to improve gait</div></li></ul></div><div id="cmt2d.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Stretching exercises, finger splints, and ankle braces to prevent contractures and deformities are appropriate.</p></div><div id="cmt2d.Surveillance"><h3>Surveillance</h3><p>Surveillance includes assessment every six months by a neurologist and/or a neuromuscular disorders specialist to assess progression of weakness in the limbs and determine the need for use of prosthetic and assistive devices.</p></div><div id="cmt2d.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Medications that are toxic or potentially toxic to persons with CMT comprise a spectrum of risk ranging from definite high risk to negligible risk. See the Charcot-Marie-Tooth Association <a href="https://www.cmtausa.org/living-with-cmt/managing-cmt/medications/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">website</a> (pdf) for an up-to-date list.</p><p>Chemotherapy for cancer that includes vincristine may be especially damaging to peripheral nerves and severely worsen CMT [<a class="bk_pop" href="#cmt2d.REF.nishikawa.2008.519">Nishikawa et al 2008</a>].</p></div><div id="cmt2d.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#cmt2d.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cmt2d.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p><p>In a mouse model of <i>GARS1</i>-associated axonal neuropathy, reduced acetylated &#x003b1;-tubulin levels were found in primary dorsal root ganglion neurons [<a class="bk_pop" href="#cmt2d.REF.benoy.2018.673">Benoy et al 2018</a>]. Selective HDAC6 inhibition increased &#x003b1;-tubulin acetylation in peripheral nerves and partially restored nerve conduction, indicating possible therapeutic potential.</p></div></div><div id="cmt2d.Genetic_Counseling"><h2 id="_cmt2d_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cmt2d.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>GARS1</i>-associated axonal neuropathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="cmt2d.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <i>GARS1</i>-associated axonal neuropathy have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>GARS1</i>-associated axonal neuropathy may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or, theoretically, <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div></li><li class="half_rhythm"><div>Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome, a milder phenotypic presentation, early death of a parent before the onset of symptoms, and/or late onset of the disease. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or known to have the <i>GARS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to sibs of inheriting the pathogenic variant is 50%. Intrafamilial clinical variability and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> have been observed.</div></li><li class="half_rhythm"><div>If the <i>GARS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#cmt2d.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>GARS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for <i>GARS1</i>-associated axonal neuropathy because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>GARS1</i>-associated axonal neuropathy is at a 50% risk of inheriting the <i>GARS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents; if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has the <i>GARS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="cmt2d.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cmt2d.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>GARS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cmt2d.Resources"><h2 id="_cmt2d_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Charcot-Marie-Tooth Association (CMTA)</b></div><div>PO Box 105</div><div>Glenolden PA 19036</div><div><b>Phone:</b> 800-606-2682 (toll-free); 610-499-9264</div><div><b>Fax:</b> 610-499-9267</div><div><b>Email:</b> info@cmtausa.org</div><div><a href="http://www.cmtausa.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmtausa.org</a></div></li><li class="half_rhythm"><div><b>European Charcot-Marie-Tooth Consortium</b></div><div>Department of Molecular Genetics</div><div>University of Antwerp</div><div>Antwerp Antwerpen B-2610</div><div>Belgium</div><div><b>Fax:</b> 03 2651002</div><div><b>Email:</b> gisele.smeyers@ua.ac.be</div></li><li class="half_rhythm"><div><b>Hereditary Neuropathy Foundation, Inc.</b></div><div>432 Park Avenue South</div><div>4th Floor</div><div>New York NY 10016</div><div><b>Phone:</b> 855-435-7268 (toll-free); 212-722-8396</div><div><b>Fax:</b> 917-591-2758</div><div><b>Email:</b> info@hnf-cure.org</div><div><a href="http://www.hnf-cure.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hnf-cure.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=distalhereditarymotorneuropathytypev" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Distal hereditary motor neuropathy, type V</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=charcotmarietoothdisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth disease</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22241/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth syndrome</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: Inherited Neuropathies Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/inc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="cmt2d.Molecular_Genetics"><h2 id="_cmt2d_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cmt2d.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>GARS-Associated Axonal Neuropathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cmt2d.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_cmt2d.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cmt2d.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cmt2d.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cmt2d.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cmt2d.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cmt2d.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cmt2d.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">CMT2D</td><td headers="hd_b_cmt2d.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2617" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GARS1</i></a></td><td headers="hd_b_cmt2d.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2617" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7p14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cmt2d.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P41250" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Glycine--tRNA ligase</a></td><td headers="hd_b_cmt2d.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://alsod.iop.kcl.ac.uk/Als/Overview/gene.aspx?gene_id=GARS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">alsod/GARS genetic mutations</a><br /><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=536" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, GARS</a><br /><a href="https://databases.lovd.nl/shared/genes/GARS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GARS homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cmt2d.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GARS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GARS1</a></td><td headers="hd_b_cmt2d.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GARS1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GARS1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cmt2d.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cmt2d.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for GARS-Associated Axonal Neuropathy (<a href="/omim/600287,600794,601472" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600287" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600287</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLYCYL-tRNA SYNTHETASE 1; GARS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600794" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600794</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601472" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601472</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D</td></tr></tbody></table></div></div><p><b>Gene.</b>
<i>GARS1</i> spans 40 kb and contains 17 exons. The 2.7-kb <i>GARS1</i> transcript is ubiquitously expressed.</p><p><b>Pathogenic variants.</b> The pathogenic variants are distributed throughout the protein in multiple functional domains. Currently, all neuropathy-associated <i>GARS1</i> mutations are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes or <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions.</p><p>To date, more than 20 pathogenic variants in <i>GARS1</i> have been reported:</p><p>&#x02022; Variants such as p.Glu125Gly, p.Leu183Pro, and p.Gly294Arg, which segregate in pedigrees with LOD scores &#x0003e;5, are known causal variants [<a class="bk_pop" href="#cmt2d.REF.christodoulou.1995.1629">Christodoulou et al 1995</a>, <a class="bk_pop" href="#cmt2d.REF.ionasescu.1996.1373">Ionasescu et al 1996</a>, <a class="bk_pop" href="#cmt2d.REF.sambuughin.1998.23">Sambuughin et al 1998</a>, <a class="bk_pop" href="#cmt2d.REF.antonellis.2003.1293">Antonellis et al 2003</a>].</p><p>&#x02022; Variants identified by sequencing <i>GARS1</i> in small families and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e<i>.</i>, a single occurrence of axonal neuropathy in a family) &#x02013; including p.Ala111Val, p.Pro298Leu, p.Ile334Phe, p.Asp554Asn, p.Gly580Arg, p.Ser635Leu, and p.Gly652Ala &#x02013; are less clearly implicated [<a class="bk_pop" href="#cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</a>, <a class="bk_pop" href="#cmt2d.REF.del_bo.2006.752">Del Bo et al 2006</a>, <a class="bk_pop" href="#cmt2d.REF.james.2006.1710">James et al 2006</a>, <a class="bk_pop" href="#cmt2d.REF.rohkamm.2007.100">Rohkamm et al 2007</a>, <a class="bk_pop" href="#cmt2d.REF.abe.2009.310">Abe &#x00026; Hayasaka 2009</a>, <a class="bk_pop" href="#cmt2d.REF.hamaguchi.2010.1202">Hamaguchi et al 2010</a>].</p><p>The p.Leu183Pro and p.His472Arg <i>GARS1</i> variants are associated exclusively with the dSMA-V clinical subtype; p.Gly294Arg, p.Ile334Phe, and p.Gly580Arg are associated with the CMT2D subtype. Families with the p.Glu125Gly, p.Pro294Leu, and p.Asp554Asn variants had both subtypes.</p><div id="cmt2d.T.gars1_pathogenic_variants_discus" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>GARS1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1242/table/cmt2d.T.gars1_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2d.T.gars1_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.332C&#x0003e;T</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala111Val<br />(p.Ala57Val)</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002047.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002047<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_002038.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002038<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.374A&#x0003e;G</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu125Gly<br />(p.Glu71Gly)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.548T&#x0003e;C</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu183Pro<br />(p.Leu129Pro)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.880G&#x0003e;C</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly294Arg<br />(p.Gly240Arg)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.893C&#x0003e;T</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro298Leu<br />(p.Pro244Leu)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1000A&#x0003e;T</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile334Phe<br />(p.Ile280Phe)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1415A&#x0003e;G</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His472Arg<br />(p.His418Arg)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1660G&#x0003e;A</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp554Asn<br />(p.Asp500Asn)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1738G&#x0003e;C</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly580Arg<br />(p.Gly526Arg)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1904C&#x0003e;T</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser635Leu<br />(p.Ser581Leu)</td></tr><tr><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1955G&#x0003e;C</td><td headers="hd_h_cmt2d.T.gars1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly652Ala<br />(p.Gly598Ala)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cmt2d.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Glycyl-tRNA synthetase, a class II aminoacyl-tRNA synthetase, performs an essential function in protein synthesis in the ribosome by catalyzing aminoacylation of glycyl-tRNA, which is required for charging tRNA with the amino acid that matches its anticodon [<a class="bk_pop" href="#cmt2d.REF.ge.1994.28790">Ge et al 1994</a>]. The enzyme must properly recognize the tRNA species and the amino acid in order to maintain fidelity of translation. In accordance with its function, glycyl-tRNA synthetase contains three domains: a catalytic core, a C-terminal anticodon recognition <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and a domain that interacts with the acceptor stem of glycyl-tRNA [<a class="bk_pop" href="#cmt2d.REF.freist.1996.343">Freist et al 1996</a>]. Glycyl-tRNA synthetase is ubiquitously expressed and absolutely necessary for protein translation in all cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> To date, all neuropathy-associated <i>GARS1</i> variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes or <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions. The vast majority impair enzyme function as assessed in enzyme kinetic and yeast complementation assays [<a class="bk_pop" href="#cmt2d.REF.griffin.2014.1363">Griffin et al 2014</a>]. However, <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is an unlikely disease mechanism based on the above alleles, the frequency of <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> alleles in the human populations, and mouse models displaying that mice carrying one null <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> have no <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> while those carrying a missense or in-frame <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have a neuropathic phenotype [<a class="bk_pop" href="#cmt2d.REF.seburn.2006.715">Seburn et al 2006</a>]. Since the identification of <i>GARS1</i> as a causal gene for CMT2D and dSMA-V, the challenge has been to determine how pathogenic missense variants in this critical and widely expressed protein cause selective degeneration of axons in peripheral nerves; both gain- and <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanisms have been proposed [<a class="bk_pop" href="#cmt2d.REF.meyerschuman.2017.r114">Meyer-Schuman &#x00026; Antonellis 2017</a>]. Further research efforts are needed for identification of specific disease mechanisms affecting peripheral axons.</p></div><div id="cmt2d.References"><h2 id="_cmt2d_References_">References</h2><div id="cmt2d.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.abe.2009.310">Abe A, Hayasaka K. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy. <span><span class="ref-journal">J Hum Genet. </span>2009;<span class="ref-vol">54</span>:310–2.</span> [<a href="/pubmed/19329989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19329989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.antonellis.2003.1293">Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, Jordanova A, Kremensky I, Christodoulou K, Middleton LT, Sivakumar K, Ionasescu V, Funalot B, Vance JM, Goldfarb LG, Fischbeck KH, Green ED. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1293–9.</span> [<a href="/pmc/articles/PMC1180282/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180282</span></a>] [<a href="/pubmed/12690580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12690580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.antoniadi.2015.84">Antoniadi T, Buxton C, Dennis G, Forrester N, Smith D, Lunt P, Burton-Jones S. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. <span><span class="ref-journal">BMC Med Genet. </span>2015;<span class="ref-vol">16</span>:84.</span> [<a href="/pmc/articles/PMC4578331/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4578331</span></a>] [<a href="/pubmed/26392352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26392352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.benoy.2018.673">Benoy V, Van Helleputte L, Prior R, d'Ydewalle C, Haeck W, Geens N, Scheveneels W, Schevenels B, Cader MZ, Talbot K, Kozikowski AP, Vanden Berghe P, Van Damme P, Robberecht W, Van Den Bosch L. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. <span><span class="ref-journal">Brain. </span>2018;<span class="ref-vol">141</span>:673–87.</span> [<a href="/pmc/articles/PMC5837793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5837793</span></a>] [<a href="/pubmed/29415205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29415205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.christodoulou.1995.1629">Christodoulou K, Kyriakides T, Hristova AH, Georgiou DM, Kalaydjieva L, Yshpekova B, Ivanova T, Weber JL, Middleton LT. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:1629–32.</span> [<a href="/pubmed/8541851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8541851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.del_bo.2006.752">Del Bo R, Locatelli F, Corti S, Scarlato M, Ghezzi S, Prelle A, Fagiolari G, Moggio M, Carpo M, Bresolin N, Comi GP. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:752–4.</span> [<a href="/pubmed/16534118" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16534118</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.divincenzo.2014.522">DiVincenzo C, Elzinga CD, Medeiros AC, Karbassi I, Jones JR, Evans MC, Braastad CD, Bishop CM, Jaremko M, Wang Z, Liaquat K, Hoffman CA, York MD, Batish SD, Lupski JR, Higgins JJ. The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2014;<span class="ref-vol">2</span>:522–9.</span> [<a href="/pmc/articles/PMC4303222/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4303222</span></a>] [<a href="/pubmed/25614874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25614874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.dubourg.2006.1721">Dubourg O, Azzedine H, Yaou RB, Pouget J, Barois A, Meininger V, Bouteiller D, Ruberg M, Brice A, LeGuern E. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:1721–6.</span> [<a href="/pubmed/16769947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16769947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.ellsworth.1999.568">Ellsworth RE, Ionasescu V, Searby C, Sheffield VC, Braden VV, Kucaba TA, McPherson JD, Marra MA, Green ED. The CMT2D locus: refined genetic position and construction of a bacterial clone-based physical map. <span><span class="ref-journal">Genome Res. </span>1999;<span class="ref-vol">9</span>:568–74.</span> [<a href="/pmc/articles/PMC310773/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC310773</span></a>] [<a href="/pubmed/10400924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10400924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.eskuri.2012.132">Eskuri JM, Stanley CM, Moore SA, Mathews KD. Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS. <span><span class="ref-journal">J Peripher Nerv Syst. </span>2012;<span class="ref-vol">17</span>:132–4.</span> [<a href="/pmc/articles/PMC3572939/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3572939</span></a>] [<a href="/pubmed/22462675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22462675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.freist.1996.343">Freist W, Logan DT, Gauss DH. Glycyl-tRNA synthetase. <span><span class="ref-journal">Biol Chem Hoppe Seyler. </span>1996;<span class="ref-vol">377</span>:343–56.</span> [<a href="/pubmed/8839980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8839980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.ge.1994.28790">Ge Q, Trieu EP, Targoff IN. Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis. <span><span class="ref-journal">J Biol Chem. </span>1994;<span class="ref-vol">269</span>:28790–7.</span> [<a href="/pubmed/7961834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7961834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.griffin.2014.1363">Griffin LB, Sakaguchi R, McGuigan D, Gonzalez MA, Searby C, Z&#x000fc;chner S, Hou YM, Antonellis A. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:1363–71.</span> [<a href="/pmc/articles/PMC4213347/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4213347</span></a>] [<a href="/pubmed/25168514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25168514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.hamaguchi.2010.1202">Hamaguchi A, Ishida C, Iwasa K, Abe A, Yamada M. Charcot-Marie-Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation. <span><span class="ref-journal">J Neurol. </span>2010;<span class="ref-vol">257</span>:1202–4.</span> [<a href="/pubmed/20169446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20169446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.ionasescu.1996.1373">Ionasescu V, Searby C, Sheffield VC, Roklina T, Nishimura D, Ionasescu R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). <span><span class="ref-journal">Hum Mol Genet. </span>1996;<span class="ref-vol">5</span>:1373–5.</span> [<a href="/pubmed/8872480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8872480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.irobi.2004a.r195">Irobi J, De Jonghe P, Timmerman V. Molecular genetics of distal hereditary motor neuropathies. <span><span class="ref-journal">Hum Mol Genet. </span>2004a;<span class="ref-vol">13</span>(Spec No 2):R195–202.</span> [<a href="/pubmed/15358725" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15358725</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.irobi.2004b.597">Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, Verpoorten N, Michalik A, De Vriendt E, Jacobs A, Van Gerwen V, Vennekens K, Mazanec R, Tournev I, Hilton-Jones D, Talbot K, Kremensky I, Van Den Bosch L, Robberecht W, Van Vandekerckhove J, Broeckhoven C, Gettemans J, De Jonghe P, Timmerman V. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. <span><span class="ref-journal">Nat Genet. </span>2004b;<span class="ref-vol">36</span>:597–601.</span> [<a href="/pubmed/15122253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15122253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.james.2006.1710">James PA, Cader MZ, Muntoni F, Childs AM, Crow YJ, Talbit K. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1710–2.</span> [<a href="/pubmed/17101916" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17101916</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.lee.2012.418">Lee HJ, Park J, Nakhro K, Park JM, Hur YM, Choi BO, Chung KW. Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V. <span><span class="ref-journal">J Peripher Nerv Syst. </span>2012;<span class="ref-vol">17</span>:418–21.</span> [<a href="/pubmed/23279345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23279345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.magy.2018.e870">Magy L, Mathis S, Le Masson G, Goizet C, Tazir M, Vallat JM. Updating the classification of inherited neuropathies: results of an international survey. <span><span class="ref-journal">Neurology. </span>2018;<span class="ref-vol">90</span>:e870–e876.</span> [<a href="/pubmed/29429969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29429969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.meyerschuman.2017.r114">Meyer-Schuman R, Antonellis A. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. <span><span class="ref-journal">Hum Mol Genet. </span>2017;<span class="ref-vol">26</span>:R114–R127.</span> [<a href="/pmc/articles/PMC5886470/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5886470</span></a>] [<a href="/pubmed/28633377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28633377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.nishikawa.2008.519">Nishikawa T, Kawakami K, Kumamoto T, Tonooka S, Abe A, Hayasaka K, Okamoto Y, Kawano Y. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2008;<span class="ref-vol">30</span>:519–21.</span> [<a href="/pubmed/18797198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18797198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.oprescu.2017.1412">Oprescu SN, Chepa-Lotrea X, Takase R, Golas G, Markello TC, Adams DR, Toro C, Gropman AL, Hou YM, Malicdan MCV, Gahl WA, Tifft CJ, Antonellis A. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation. <span><span class="ref-journal">Hum Mutat. </span>2017;<span class="ref-vol">38</span>:1412–20.</span> [<a href="/pmc/articles/PMC5599332/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5599332</span></a>] [<a href="/pubmed/28675565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28675565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.rohkamm.2007.100">Rohkamm B, Reilly MM, Lochm&#x000fc;ller H, Schlotter-Weigel B, Barisic N, Sch&#x000f6;ls L, Nicholson G, Pareyson D, Laur&#x000e0; M, Janecke AR, Miltenberger-Miltenyi G, John E, Fischer C, Grill F, Wakeling W, Davis M, Pieber TR, Auer-Grumbach M. Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. <span><span class="ref-journal">J Neurol Sci. </span>2007;<span class="ref-vol">263</span>:100–6.</span> [<a href="/pmc/articles/PMC3272403/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3272403</span></a>] [<a href="/pubmed/17663003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17663003</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.sambuughin.1998.23">Sambuughin N, Sivakumar K, Selenge B, Lee HS, Friedlich D, Baasanjav D, Dalakas MC, Goldfarb LG. Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15. <span><span class="ref-journal">J Neurol Sci. </span>1998;<span class="ref-vol">161</span>:23–8.</span> [<a href="/pubmed/9879677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9879677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.seburn.2006.715">Seburn KL, Nangle LA, Cox GA, Schimmel P, Burgess RW. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. <span><span class="ref-journal">Neuron. </span>2006;<span class="ref-vol">51</span>:715–26.</span> [<a href="/pubmed/16982418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16982418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2d.REF.sivakumar.2005.2304">Sivakumar K, Kyriakides T, Puls I, Nicholson GA, Funalot B, Antonellis A, Sambuughin N, Christodoulou K, Beggs JL, Zamba-Papanicolaou E, Ionasescu V, Dalakas MC, Green ED, Fischbeck KH, Goldfarb LG. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. <span><span class="ref-journal">Brain. </span>2005;<span class="ref-vol">128</span>:2304–14.</span> [<a href="/pubmed/16014653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16014653</span></a>]</div></li></ul></div></div><div id="cmt2d.Chapter_Notes"><h2 id="_cmt2d_Chapter_Notes_">Chapter Notes</h2><div id="cmt2d.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health.</p></div><div id="cmt2d.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 November 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 August 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 January 2007 (lgg) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> clinically available for mutations in <i>GARS</i></div></li><li class="half_rhythm"><div>8 November 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>24 February 2006 (lgg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1242</span><span class="label">PMID: <a href="/pubmed/20301420" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301420</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/g6pc3-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gata1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1242&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1242/?report=reader">PubReader</a></li><li><a href="/books/NBK1242/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1242" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1242" style="display:none" title="Cite this Page"><div class="bk_tt">Antonellis A, Goldfarb LG, Sivakumar K. GARS1-Associated Axonal Neuropathy. 2006 Nov 8 [Updated 2018 Nov 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1242/pdf/Bookshelf_NBK1242.pdf">PDF version of this page</a> (335K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cmt2d.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cmt2d.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#cmt2d.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cmt2d.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cmt2d.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cmt2d.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cmt2d.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cmt2d.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cmt2d.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cmt2d.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cmt2d.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cmt2d.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26580[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BSCL2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2617[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GARS1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1483458" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1483458" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1483458" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1483458" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301462" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20614582" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Züchner S, Tao F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301641" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24830047" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schindler A, Sumner C, Hoover-Fong JE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16014653" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.</a><span class="source">[Brain. 2005]</span><div class="brieflinkpop offscreen_noflow">Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sivakumar K, Kyriakides T, Puls I, Nicholson GA, Funalot B, Antonellis A, Sambuughin N, Christodoulou K, Beggs JL, Zamba-Papanicolaou E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain. 2005 Oct; 128(Pt 10):2304-14. Epub 2005 Jul 13.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301420" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301420" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9350dd21425a25ca98c7">GARS1-Associated Axonal Neuropathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">GARS1-Associated Axonal Neuropathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:24:32-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DE383DFC83FD100000000076F037C&amp;ncbi_session=CE8DE383DFC934F1_1903SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1242%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1242&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1242/&amp;ncbi_pagename=GARS1-Associated Axonal Neuropathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DE383DFC934F1_1903SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>